ING Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.3M | Sell |
26,700
-1,764
| -6% | -$654K | 0.05% | 241 |
|
|
2026
Q1 | $8.33M | Sell |
28,464
-257
| -0.9% | -$84.5K | 0.05% | 227 |
|
|
2025
Q4 | $10.1M | Sell |
28,721
-389
| -1% | -$131K | 0.06% | 193 |
|
|
2025
Q3 | $9.41M | Sell |
29,110
-619
| -2% | -$193K | 0.05% | 197 |
|
|
2025
Q2 | $11.6M | Buy |
29,729
+115
| +0.4% | +$46.3K | 0.07% | 159 |
|
|
2025
Q1 | $12.9M | Sell |
29,614
-7
| -0% | -$2.81K | 0.09% | 145 |
|
|
2024
Q4 | $10.9M | Buy |
+29,621
| New | +$12.4M | 0.07% | 183 |
|
|
2024
Q1 | – | Sell |
-2,374
| Closed | -$1.12M | – | 576 |
|
|
2023
Q4 | $1.12M | Buy |
+2,374
| New | +$1.1M | 0.01% | 474 |
|
|
2023
Q2 | – | Sell |
-784
| Closed | -$360K | – | 586 |
|
|
2023
Q1 | $360K | Sell |
784
-39,823
| -98% | -$19M | ﹤0.01% | 487 |
|
|
2022
Q4 | $20.8M | Buy |
40,607
+2,992
| +8% | +$1.52M | 0.21% | 95 |
|
|
2022
Q3 | $17.1M | Sell |
37,615
-7,752
| -17% | -$3.71M | 0.29% | 77 |
|
|
2022
Q2 | $21.9M | Buy |
45,367
+6,859
| +18% | +$3.39M | 0.25% | 74 |
|
|
2022
Q1 | $18.9M | Buy |
38,508
+6,829
| +22% | +$3.12M | 0.19% | 95 |
|
|
2021
Q4 | $14.7M | Buy |
31,679
+11,210
| +55% | +$4.72M | 0.13% | 139 |
|
|
2021
Q3 | $7.63M | Buy |
20,469
+360
| +2% | +$137K | 0.1% | 139 |
|
|
2021
Q2 | $7.68M | Buy |
20,109
+3,894
| +24% | +$1.49M | 0.12% | 112 |
|
|
2021
Q1 | $5.82M | Sell |
16,215
-281
| -2% | -$90.4K | 0.12% | 108 |
|
|
2020
Q4 | $5.3M | Buy |
16,496
+10,930
| +196% | +$3.35M | 0.12% | 113 |
|
|
2020
Q3 | $1.5M | Sell |
5,566
-66,566
| -92% | -$17.9M | 0.06% | 156 |
|
|
2020
Q2 | $19M | Buy |
+72,132
| New | +$19.2M | 0.82% | 25 |
|
|
2020
Q1 | – | Sell |
-17,392
| Closed | -$5.25M | – | 431 |
|
|
2019
Q4 | $5.25M | Buy |
17,392
+1,428
| +9% | +$393K | 0.16% | 108 |
|
|
2019
Q3 | $3.83M | Sell |
15,964
-7,003
| -30% | -$1.92M | 0.1% | 145 |
|
|
2019
Q2 | $6.48M | Sell |
22,967
-15,312
| -40% | -$4.18M | 0.11% | 131 |
|
|
2019
Q1 | $11M | Buy |
38,279
+8,201
| +27% | +$2.37M | 0.24% | 70 |
|
|
2018
Q4 | $7.9M | Sell |
30,078
-5,518
| -16% | -$1.52M | 0.17% | 93 |
|
|
2018
Q3 | $9.76M | Buy |
+35,596
| New | +$9.24M | 0.17% | 88 |
|
|
2018
Q2 | – | Sell |
-26,128
| Closed | -$5.74M | – | 757 |
|
|
2018
Q1 | $5.74M | Buy |
+26,128
| New | +$6.14M | 0.1% | 119 |
|
|
2017
Q3 | – | Sell |
-15,401
| Closed | -$2.9M | – | 839 |
|
|
2017
Q2 | $2.9M | Buy |
+15,401
| New | +$2.77M | 0.06% | 174 |
|
|
2017
Q1 | – | Sell |
-22,383
| Closed | -$3.24M | – | 588 |
|
|
2016
Q4 | $3.24M | Buy |
22,383
+11,498
| +106% | +$1.54M | 0.06% | 174 |
|
|
2016
Q3 | $1.36M | Buy |
10,885
+7,159
| +192% | +$924K | 0.02% | 253 |
|
|
2016
Q2 | $489K | Buy |
+3,726
| New | +$510K | 0.01% | 338 |
|
|
2016
Q1 | – | Sell |
-211,388
| Closed | -$29.5M | – | 586 |
|
|
2015
Q4 | $29.5M | Sell |
211,388
-92,922
| -31% | -$12.8M | 0.18% | 139 |
|
|
2015
Q3 | $42.6M | Buy |
304,310
+4,034
| +1% | +$606K | 0.29% | 81 |
|
|
2015
Q2 | $49.3M | Buy |
300,276
+24,000
| +9% | +$3.83M | 0.27% | 80 |
|
|
2015
Q1 | $42.7M | Buy |
276,276
+6,254
| +2% | +$890K | 0.21% | 103 |
|
|
2014
Q4 | $33.9M | Buy |
270,022
+29,529
| +12% | +$3.65M | 0.16% | 140 |
|
|
2014
Q3 | $28.8M | Buy |
240,493
+18,722
| +8% | +$2.15M | 0.17% | 136 |
|
|
2014
Q2 | $23.9M | Sell |
221,771
-17,721
| -7% | -$1.83M | 0.12% | 170 |
|
|
2014
Q1 | $23.9M | Buy |
239,492
+17,767
| +8% | +$1.61M | 0.13% | 179 |
|
|
2013
Q4 | $20.5M | Buy |
221,725
+82,042
| +59% | +$7.29M | 0.1% | 204 |
|
|
2013
Q3 | $11.7M | Sell |
139,683
-268,636
| -66% | -$23M | 0.06% | 269 |
|
|
2013
Q2 | $33.4M | Buy |
+408,319
| New | +$30.6M | 0.18% | 139 |
|
Other funds holding ELV
ING Group's ELV Position: Q2 2026 in Review
ING Group reduced its Elevance Health (ELV) stake by 6.2% in Q2 2026, selling an estimated $654K and leaving 26,700 shares worth $10.3M. The position accounts for 0.05% of the portfolio, ranked #241.
ING Group first reported a position in ELV in Q2 2013 and has held it in 42 quarters since. The position peaked at $49.3M in Q2 2015. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- ING Group held 26,700 shares of Elevance Health worth $10.3M as of Q2 2026.
- ING Group sold 1,764 Elevance Health shares in Q2 2026, an estimated $654K.
- Elevance Health made up 0.05% of ING Group's portfolio in Q2 2026, its #241 holding.
- ING Group first reported a position in Elevance Health in Q2 2013 and has held it in 42 quarters since.
- ING Group's Elevance Health position peaked at $49.3M in Q2 2015.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.